Funding for this research was provided by:
from the Chinese National Science and Technology (2012ZX10004-220)
China UK Global Health Support Programme (GHSP-CS-OP1)
International Collaboration Project from the Ministry of Science and Technology (2010DF33970)
CASTEP (China-Africa science and technology program)
Received: 11 September 2019
Accepted: 12 February 2020
First Online: 18 March 2020
Ethics approval and consent to participate
: Parents or guardian were provided a written informed consent before enrollment in this study, in accordance with the principles of the World Health Assembly of 1975 on Ethics in Human experimentation and the Helsinki Declaration. All malaria patients received anti-malarial drugs free of charge. This study was approved by the Ethics Committees of the Cameroon Ministry of Public Health and by the provincial CDC authorities and registered in NIH U.S. National Library of Medicine, ClinicalTrials.gov on the 28/11/2016 at ExternalRef removed with the registration number NCT02974348.
: Not applicable.
: The authors declare that they have no competing interests.